Israel Englander Immuno Gen, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.46 - $29.95 $22.1 Million - $53.2 Million	1,776,005 Added 65.83%	4,473,868 $133 Million
Q2 2023 Aug 14, 2023	SELL	$3.75 - $20.05 $1.05 Million - $5.6 Million	-279,061 Reduced 9.37%	2,697,863 $50.9 Million
Q1 2023 May 15, 2023	BUY	$3.67 - $4.92 $7.5 Million - $10.1 Million	2,043,204 Added 218.82%	2,976,924 $11.4 Million
Q4 2022 Feb 14, 2023	SELL	$4.55 - $6.31 $4.13 Million - $5.72 Million	-907,117 Reduced 49.28%	933,720 $4.63 Million
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $14.4 Million - $20.8 Million	-3,216,212 Reduced 63.6%	1,840,837 $8.8 Million
Q2 2022 Aug 15, 2022	BUY	$3.15 - $5.76 $4.9 Million - $8.97 Million	1,557,032 Added 44.49%	5,057,049 $22.8 Million
Q1 2022 May 16, 2022	SELL	$4.26 - $7.48 $6.6 Million - $11.6 Million	-1,549,274 Reduced 30.68%	3,500,017 $16.7 Million
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $9.98 Million - $15.8 Million	2,101,770 Added 71.31%	5,049,291 $37.5 Million
Q3 2021 Nov 15, 2021	BUY	$5.02 - $6.59 $1.63 Million - $2.14 Million	324,613 Added 12.38%	2,947,521 $16.7 Million
Q2 2021 Aug 16, 2021	BUY	$5.79 - $8.6 $2.2 Million - $3.27 Million	380,607 Added 16.97%	2,622,908 $17.3 Million
Q1 2021 May 17, 2021	BUY	$6.5 - $10.53 $1.88 Million - $3.04 Million	288,827 Added 14.79%	2,242,301 $18.2 Million
Q4 2020 Feb 16, 2021	SELL	$3.7 - $7.66 $10.4 Million - $21.5 Million	-2,801,900 Reduced 58.92%	1,953,474 $12.6 Million
Q3 2020 Nov 16, 2020	BUY	$3.45 - $4.89 $2.65 Million - $3.76 Million	769,380 Added 19.3%	4,755,374 $17.1 Million
Q2 2020 Aug 14, 2020	BUY	$3.32 - $5.34 $6.67 Million - $10.7 Million	2,007,736 Added 101.49%	3,985,994 $18.3 Million
Q1 2020 May 14, 2020	SELL	$2.12 - $6.8 $2.1 Million - $6.74 Million	-991,321 Reduced 33.38%	1,978,258 $6.75 Million
Q4 2019 Feb 14, 2020	BUY	$2.25 - $5.8 $2.36 Million - $6.07 Million	1,046,725 Added 54.44%	2,969,579 $15.2 Million
Q3 2019 Nov 14, 2019	SELL	$2.22 - $3.39 $655,346 - $1 Million	-295,201 Reduced 13.31%	1,922,854 $4.65 Million
Q2 2019 Aug 14, 2019	BUY	$1.8 - $3.3 $1.69 Million - $3.09 Million	936,879 Added 73.13%	2,218,055 $4.81 Million
Q1 2019 May 14, 2019	SELL	$2.41 - $5.91 $7.49 Million - $18.4 Million	-3,108,084 Reduced 70.81%	1,281,176 $3.47 Million
Q4 2018 Feb 14, 2019	BUY	$3.94 - $9.7 $14 Million - $34.5 Million	3,552,118 Added 424.31%	4,389,260 $21.1 Million
Q3 2018 Nov 14, 2018	BUY	$8.6 - $11.26 $4.99 Million - $6.53 Million	579,938 Added 225.48%	837,142 $7.93 Million
Q2 2018 Aug 14, 2018	SELL	$9.52 - $12.15 $13.1 Million - $16.7 Million	-1,373,778 Reduced 84.23%	257,204 $2.5 Million
Q1 2018 May 15, 2018	SELL	$6.7 - $12.95 $8.78 Million - $17 Million	-1,310,505 Reduced 44.55%	1,630,982 $17.2 Million
Q4 2017 Feb 14, 2018	SELL	$5.07 - $7.92 $4.29 Million - $6.7 Million	-845,940 Reduced 22.34%	2,941,487 $18.9 Million
Q3 2017 Nov 14, 2017	BUY	$5.4 - $8.47 $20.5 Million - $32.1 Million	3,787,427	3,787,427 $29 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account